CPT® Code 87901

The CPT® Code 87901 refers to the process of conducting an infectious agent genotype analysis specifically for the HIV-1 virus. This analysis focuses on the reverse transcriptase and protease regions of the virus's genetic material, which is either DNA or RNA. The primary purpose of this test is to identify mutations within the HIV-1 genes that may lead to resistance against 19 commonly prescribed medications known as reverse transcriptase and protease inhibitors. These medications are critical in the treatment of HIV-1, a virus that significantly compromises the immune system by targeting and destroying T cells, also known as CD4 cells, which are essential for the body's ability to combat infections. HIV is the causative agent of acquired immunodeficiency syndrome (AIDS), which represents the most advanced stage of HIV infection. As an RNA virus, HIV has a high replication rate, and the reverse transcription process necessary for its replication can introduce mutations into its genetic code. Some of these mutations can result in the virus developing resistance to antiviral drugs, making treatment less effective. To combat this, initial treatment for HIV typically involves a combination of antiretroviral medications that work through various mechanisms to lower the viral load and minimize the risk of mutations that lead to drug resistance. This approach is known as highly active antiretroviral therapy (HAART). However, when the initial treatment fails, a genotype analysis is performed to assess the reverse transcriptase and protease genes for known mutations associated with drug resistance. The genotyping process is intricate and requires a blood sample to evaluate the presence of specific nucleic acid sequences associated with HIV-1. The procedure involves three main steps: first, the amplification of specific nucleic acid sequences using techniques such as polymerase chain reaction (PCR); second, the purification of the amplified product followed by further molecular analysis; and finally, the comparison of the amplified sequences to established sequences that are known to confer drug resistance. The results of this analysis are crucial for developing a more effective drug regimen tailored to better control the HIV infection.